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Objective: The efficacy of polestriding exercise (walking with modified ski poles with a movement pattern similar to
cross-country skiing) to increase exercise tolerance of persons with intermittent claudication pain caused by peripheral
arterial disease was tested in this 24-week prospective randomized clinical trial.
Methods: The study was conducted in a Department of Veterans Affairs Hospital with 52 individuals who gave written
informed consent and were randomized into either a polestriding exercise (n  27; age, 65.5  7.0 years; ankle brachial
index, 0.64 0.25) or nonexercise control (n 25; age, 68.6 8.9 years; ankle brachial index, 0.69 0.14) group (P >
.05 for all comparisons). The polestriding exercise program consisted of supervised training three times per week for 4
weeks, two times per week for 8 weeks, one time per week for 4 weeks, biweekly for 4 weeks and unsupervised training
for 4 weeks. Starting in week 5, subjects took their poles home with instructions to repeat the most recent supervised
training walk at an appropriate and convenient location near their residence. This was referred to as unsupervised but
directed exercise. Subjects were provided with a personal log book for documenting unsupervised exercise sessions. With
both supervised and unsupervised exercise, subjects were expected to complete a total of four 30-minute to 45-minute
polestriding exercise sessions per week. The main outcome measures were exercise duration on symptom-limited
incremental treadmill test, Walking Impairment Questionnaire, rating of perceived leg pain at baseline, 4, 8, 12, 16, and
24 weeks, and constant work-rate treadmill exercise tests at baseline and at 4, 12, and 24 weeks.
Results: Polestriding significantly (P < .001) improved exercise tolerance on the constant work-rate and incremental
treadmill tests. Ratings of perceived claudication pain were significantly less after the polestriding training program.
Subject perceived distance and walking speed scores on the Walking Impairment Questionnaire improved in the
polestriding trained group only (P < .001 and .022, respectively).
Conclusion: This randomized clinical trial provides empirical evidence that 24 weeks of polestriding training significantly
improves quantitative and qualitative measures of the exercise tolerance of persons limited by intermittent claudication
pain. (J Vasc Surg 2002;35:887-93.)
Patients with atherosclerotic peripheral arterial disease
(PAD) of the lower extremities are subject to periods of
intermittent claudication (IC) caused by the formation of
atherosclerotic plaques that narrow or occlude arteries.
This condition results in an inadequate blood flow that
causes ischemic muscle pain. The ability of patients with
PAD to walk on level ground for more than a short distance
is variably impaired. Moreover, the peak exercise capacity of
these individuals, measured during treadmill walking, is
well below that expected for age-matched and gender-
matched cohorts. Disability may result when the patient
can no longer meet the daily demands of personal, social, or
occupational activities.1 The purpose of this prospective,
randomized clinical trial was to evaluate the efficacy of
polestriding exercise to increase exercise tolerance of per-
sons with IC pain caused by PAD. The total walking
time/distance on a constant workload treadmill (CWT)
exercise test by subjects randomized to polestriding was
hypothesized to be significantly greater and rating of per-
ceived claudication pain to be less than with nonexercise
control group subjects. Polestriding is walking/striding
with modified ski poles while coordinating the upper and
lower extremities in a sequence of movements that are
similar to the poling mechanics used in classic style cross-
country skiing. This report uses data collected in a random-
ized double-blind (medication only) study design in which
one of the purposes, in addition to that stated previously,
was to evaluate the effect of vitamin E (-tocopherol)
supplementation on exercise tolerance and claudication.
Because vitamin E did not influence exercise tolerance, the
groups were merged.
METHODS
Subjects. Volunteers were recruited from the hospi-
tal’s Peripheral Vascular and Outpatient Clinics, through
contact with local physician groups, participation in health
fairs, and veteran publications. Seventy-three individuals
satisfied the inclusion criteria and gave written informed
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consent. Of this group of qualifying volunteers, 51 men
and one woman completed baseline testing and were ran-
domized (Table I). Individuals selected to participate in the
study had a current diagnosis of PAD, a history of IC, and
an ankle brachial index (ABI) of less than 0.95 at rest or less
than 0.85 after exercise. Pain from IC must have been the
primary limiting factor to maximal exercise performance
during a treadmill test. Study participants must have re-
ported a diminished capacity to complete leisure-time and
occupational activities because of claudication pain. Pa-
tients with severe leg pain at rest, ischemic ulceration,
gangrene, resting ABI of less than 40 mm Hg, vascular
surgery or angioplasty within the previous year, current use
of vitamin E, warfarin sodium, or pentoxifylline, or exercise
capacity limited by factors other than PAD were excluded
from the study. All randomized subjects were reimbursed
$6 for each training visit to defray travel costs and in
increasing increments of $5 for each testing battery they
completed, starting at $25.00.
Overview of study design. This study was a prospec-
tive, randomized clinical trial. The institution’s Human
Studies Subcommittee approved the experimental protocol
and informed consent. After initial screening, patients un-
derwent, for the purpose of cardiovascular disease screen-
ing, a symptom-limited maximal wheelchair exercise test.2
If electrocardiographic results were positive, the subject did
not begin baseline testing unless appropriate follow-up
evaluation was completed and the study cardiologist (LCE)
approved further participation.
At baseline, all subjects repeated a minimum of two
symptom-limited incremental treadmill tests. Poles were
not used during treadmill testing. Metabolic and hemody-
namic measures were taken before, during, and after each
test. Supine ABI was determined before and after treadmill
walking. During exercise, subject perception of claudica-
tion pain and exertion was determined every 60 seconds
with Borg’s ratio scale.3 After 72 hours, the second baseline
incremental treadmill test was completed. If walking times
between the two tests differed by more than 10%, a third
treadmill test was necessitated. All subjects repeated the
incremental treadmill test at 4, 8, 12, 16, and 24 weeks.
Subjects also underwent a CWT test at baseline, 1, 3, and 6
months. After baseline testing, subjects were randomized
into either the polestriding exercise or control groups.
Subjects in the polestriding exercise group received
polestriding instruction and training. Individuals in the
control group came to the laboratory biweekly for ABI
measurements.
Physiologic and psychophysical measurements. In
addition to walking duration and distance, the following
measures were taken/recorded during all exercise tests.
Expired gases were collected breath-by-breath and ana-
lyzed with a SensorMedics 2900 metabolic cart (Yorba
Linda, Calif) to determine oxygen uptake. Measures were
averaged every 30 seconds. Before and after each test, the
analyzers were calibrated with reference gases and room air.
Heart rate (HR) was derived from a 12-lead electrocardio-
gram every minute. Blood pressure (BP) was measured be-
fore exercise, every 2 minutes during exercise, and every
minute after exercise until BP approached baseline values.
After a standardized procedure, ratings of perceived leg
claudication pain and exertion were obtained during the
last 30 seconds of each stage of exercise with Borg’s ratio
scale.3 Doppler ultrasound scan was used to measure the
supine ankle to arm systolic BP ratio, or ABI, for the most
severely affected leg before exercise, within 120 to 150
seconds after exercise, and every 2 minutes up to 20 min-
utes or until ABI returned to the preexercise level. The
Walking Impairment Questionnaire (WIQ)1 was adminis-
tered via interview by a trained member of the research
team. The WIQ was used to quantify patient perceived
degree of difficulty regarding walking distance and speed.
Incremental symptom-limited treadmill test. With
Hiatt et al’s4 recommendations for optimizing treadmill
tests for patients with PAD, a new protocol was developed
for this study.5 Exercise began at 0% grade and speed of 1.8
mph (3.0 km/h). Grade increased by 0.5% every 30
seconds. After 6 minutes, speed was increased 0.2 mph
(0.3 km/h) every 3 minutes. The protocol was designed
so that the estimated metabolic requirements increased by
one metabolic equivalent every 3 minutes.6
Constant work-rate treadmill test. Treadmill speed
and grade were held constant at 1.8 mph and 12%, respec-
tively. No metabolic measures were taken during the CWT
test. Subjects walked until forced to stop by IC pain or a
time limit of 45 minutes.
Polestriding exercise program. The polestriding ex-
ercise program consisted of supervised training three times
per week for 4 weeks, twice per week for 8 weeks, once per
week for 4 weeks, biweekly for 4 weeks, and unsupervised
training for 4 weeks. Subjects completed a 1-hour instruc-
tion/orientation that included a videotape, demonstration,
and practice. EXERSTRIDER poles (EXERSTRIDER
Products Inc, Madison, Wis) were purchased in different
lengths (weight,369 to 397 g) and issued to participants
Table I. Characteristics of 52 subjects randomized to the
PoleStriding (n  27) and nonexercise control (n  25)
groups. Some data are based on the subjects’ self-report







Age (y) 65.5  6.8 68.7  8.8
Height (cm) 173.2  7.1 177.2  4.7
Weight (kg) 85.8  16.7 88.9  16.8
Body mass index 28.6  4.9 28.4  5.4
Ankle brachial index 0.64  0.25 0.69  0.14
Education (highest grade) 12.0  2.7 13.0  2.1
Smoking (pack y) 61.5  36.4 53.9  36.0




Body mass index  body weight (kg)  height (m2).
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in accordance with published sizing guidelines.7 All
poleStriding training sessions included warm up, range of
motion exercises, poleStriding interval training, cool down,
and postexercise range of motion exercises. Subject training
programs were individualized on the basis of the results of
the most recent incremental treadmill exercise test. During
training, subject HR, BP, ratings of effort, and perceived
leg pain/discomfort were recorded at appropriate intervals.
In week 5, subjects began taking their poles home with
instructions to repeat the last training walk at a location
near their residence. The objectives of this unsupervised
exercise were to increase the weekly volume of exercise to 4
to 5 day  week1 and to habituate subjects to a daily
routine that included exercise. Subjects used a personal log
book to record/report information similar to that collected
during supervised training sessions.
Interval training was used throughout the program.
Intermittent bouts of exercise allow for a higher total
volume of more intense work. Before each training session,
the subject was familiarized with the workout and changes
were explained. Training was varied by the amount of
upper body effort used during poling, increasing or de-
creasing walking speed, combined changes in walking
speed and poling effort, the amount of time allowed for rest
intervals, and changes in terrain. Frequent measures of HR
and exertion served as indicators of exercise strain.
Much of the training was conducted out-of-doors;
however, seasonal variation in the weather forced the pro-
gram indoors for a number of months. A Trackmaster
TM500-E AC treadmill (JAS Manufacturing, Carrollton,
Tex) with a belt size of 6 3 feet (1.83 0.91 m) was used
for indoor training.
Nonexercise control group. Subjects in the control
group continued to receive standard medical care. To con-
trol for attention bias, subjects were seen biweekly by the
study staff for the first 3 months and monthly thereafter.
During each visit, body weight, HR, BP, and ABI were
measured.
Statistical analysis. The longest time walked on the
two baseline symptom-limited incremental treadmill tests
that were within 10% of each other was used as the pretrain-
ing (baseline) walking endurance time in all analyses. The
change in WIQ aggregate scores from baseline to the end of
the study was calculated for each patient, and the difference
between the polestriding and control groups was evaluated
with a one-way analysis of variance (ANOVA). Differences
between aggregate scores at baseline, 4, 12, and 24 weeks
within groups were analyzed with a paired t test with a
Bonferroni correction for multiple comparisons. One-way
ANOVA was used to determine the significance of the
differences in duration of exercise on the incremental and
CWT tests and peak oxygen uptake on the incremental
treadmill test.
The slope of the relationship between rating of per-
ceived leg pain and time of exercise on the CWT test was
determined for each subject with linear regression proce-
dures. Differences in derived slopes between the polestrid-
ing and control groups were tested with Student indepen-
dent t test. An  of less than .05 was required for statistical
significance. The experiment-wise error rate was preserved
in all analyses at an  of .05.
RESULTS
Baseline symptom-limited incremental treadmill
exercise testing. To establish a stable baseline for tread-
mill testing, subjects completed the incremental treadmill
test protocol at least twice. If the duration on the second
test was within 10% of the first, the subject continued with
other baseline testing. If the difference exceeded 10%, the
subject’s metabolic values (V˙O2, mL  kg
1  min1) were
compared to find whether they differed by more than 5%. If
the variation of both duration and peak oxygen uptake
exceeded the a priori limits, the subject completed a third
test. Of the randomized subjects, the percent difference in
duration was 5.8% 3.1% in 42 subjects. Metabolic values
were used to compare treadmill tests in the eight remaining
subjects. The average difference between tests in these cases
was 3.5% 2.8%. Seventeen randomized subjects needed a
third test. After repeated testing, one volunteer was re-
moved from the study because a stable baseline could not
be established. Two subjects who participated in the study
did not complete a repeat baseline treadmill test for the
following reasons: (1) at the time of enrollment, the pa-
tient’s doctor requested he only complete one maximal
exercise test; and (2) a volunteer was accidentally random-
ized to a treatment group before completing the second
exercise test.
Constant work-rate treadmill test. By 6 months, the
polestriding exercise group improved baseline exercise time
by 18 minutes 18 seconds (181%) or a distance of 0.88
kilometers, whereas the control group decreased walking
time by 7 seconds (1%). Polestriding training significantly
affected duration (F  29.42; P 	 .001). Observed power
for the polestriding exercise effect was 1.51 and for the
control condition was 0.02.
At baseline, no significant between-group difference in
duration on the CWT test was found (polestriding: 10:
06  8:39 min:s; control: 11:00  8:44 min:s; P  .72).
Significant differences were found between the groups as
early as 4 weeks (polestriding: 19:11  16:49 min:s; con-
trol: 10:23  5:59 min:s; P  .029) and continued to
increase at 12 weeks (polestriding: 20:42  18:53 min:s;
control: 11:11  8:41 min:s; P  .039) and 24 weeks
(polestriding: 28:24  19:16 min:s; control: 10:54 
11:48 min:s; P 	 .0001).
Symptom-limited incremental treadmill exercise
test. Significant differences in exercise time from baseline
were found after 12 weeks of polestriding training (Table
II). The polestriding group improved duration on the
incremental treadmill test by 23% at 4 weeks, 31% at 8
weeks, 40% at 12 weeks, 47% at 16 weeks, and 51% at 24
weeks. Conversely, the control group’s duration of exercise
declined by 9% at 4 weeks, 7% at 8 weeks, 9% at 12 weeks,
14% at 16 weeks, and 7% at 24 weeks.
Peak oxygen uptake consistently increased after the
baseline assessment in the polestriding group but not in the
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control group. The mean increases in peak oxygen uptake
during the 24-week training period were significant in the
polestriding group (mean increase, 2.76 mL  kg1  min1;
P	 .0001) but not in the control group (mean increase, 0.28
mL  kg1  min1; P .389).
Arterial blood flow in the legs. Repeated measures
ANOVA was used to test the effect of the experimental
conditions on subject resting preexercise ABI and 2-minute
postexercise ABI for the CWT test at baseline, 1, 3 and 6
months. No training effect was seen on resting ABI (F 
1.02; P  .40) or 2-minute postexercise ABI (F  0.41;
P  .74).
Rating of perceived leg claudication pain. The slope
of the relationship between perceived leg pain and exercise
time during the CWT test was determined for each subject
for all CWT tests with the least squares method. At base-
line, the average slope of the regression lines for perceived
leg pain in the polestriding and control groups were equiv-
alent (polestriding: 1.30 1.25; control: 1.08 0.91; P
.51). Significant differences in mean slope were found at
the time of the last CWT test (polestriding, 0.27  0.30;
control, 0.95 0.73; P	 .001). During a 6-month period,
mean slope decreased only 12% in the control group versus
79% in the polestriding group (Fig).
Walking impairment questionnaire. On the basis of
an analysis of change scores, the polestriding group re-
ported significantly greater perceived ability to walk dis-
tance than the control group at 4 (P .05), 12 (P .001),
and 24 (P  .002) weeks. Moreover, the polestriding
group rated their perceived ability to walk faster to be
significantly greater than the control group at 4 (P  .03),
12 (P .19), and 24 (P .02) weeks. The groups’ ratings
were equivalent at baseline (P 
 .05). In the polestriding
group, the polestriding aggregate scores for both distance
and speed improved significantly between baseline and 12
weeks (P	 .0001) and baseline and 24 weeks (P	 .0001)
but not between 12 and 24 weeks (P
 .015). The percep-
tion of walking speed and distance did not improve in the
control group.
DISCUSSION
Subject adherence and compliance. Only six subjects
failed to complete the study. Three withdrew for nonmed-
ical reasons and three for medical reasons, including severe
exacerbation of osteoarthritis, frequent hospitalizations for
psychologic instability, and an accident resulting in injuries.
Subject adherence to supervised training (weeks 1 to
12) was nearly perfect. Exceptions were primarily related to
illness. Compliance with unsupervised but directed exercise
was less successful. Fewer than 50% of subjects maintained
a regular program of exercise without supervision. Analysis
of the subject exercise logs showed noncompliance with
unsupervised training, and concurrent decrements were
seen in work tolerance during supervised sessions. Because
adherence to unsupervised training was not a primary out-
come in this study, subjects were offered the option of
returning to a schedule of 2 to 3 supervised sessions per
week. A 100% acceptance of this option was found when it
was offered. As a result, the program was transformed into
24 weeks of supervised polestriding training. Reasons for
not training on their own included: 1, inclement weather;
2, neighborhood not conducive to exercising safely; and 3,
uncomfortable walking with poles in public. In a substantial
number of subjects, motivation to exercise independently
without regular supervision/encouragement was low. This
was a disappointing, although not unanticipated, outcome.
Given the success of supervised polestriding exercise in
improving exercise tolerance, the development of alterna-
tive strategies to promote adherence to unsupervised exer-
cise should be investigated further.
Appropriateness of polestriding exercise in the re-
habilitation of patients with peripheral artery disease: a
hypothesis. “Walking pole/sticks” have long been used
by walkers (hikers, mountaineers) for several reasons (eg,
increased base of support and improved balance when
walking over uneven terrain and a decrease in lower extrem-
ity loading and strain).8-11 Recently, people have begun
using poles during aerobic exercise because of mounting
evidence that HR and oxygen consumption (caloric expen-
Table II. Mean ( one standard deviation) for exercise duration (seconds) and oxygen uptake on the incremental
treadmill exercise test for subjects in the PoleStriding and nonexercise control groups. Probability values for the one-way








P valuePoleStriding Nonexercise PoleStriding Nonexercise
Baseline 626  246 664  282 .600 16.7  4.0 16.7  3.3 .994
4 768  292 602  246 .038 17.5  4.4 15.8  2.9 .112
8 819  286 616  246 .017 17.9  4.5 15.6  3.2 .065
12 877  272 604  224 .001 18.0  4.0 15.9  3.2 .068
16 921  262 572  241 	.001 18.7  4.8 15.3  3.4 .015
24 944  268 620  280 	.001 18.7  4.5 15.6  3.5 .017
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diture) are markedly greater when walking with poles.8 In
our laboratory, six individuals completed repeated
5-minute bouts of treadmill walking (grade and no grade
conditions) with and without poles. Subjects rested 5 min-
utes before exercise, exercised for 5 minutes, and were
given 5 minutes for recovery or longer as needed ( 10
beats  min1 of preexercise HR). Testing order was not
randomized, and polestriding trials always followed walk-
ing. The percentage increase in oxygen uptake, HR, and
kcal  min1 with walking with poles compared with walk-
ing without poles was 29  16, 13  10, and 32  17 for
the no grade condition and 24 12, 12 8, and 26 13
with grade, respectively (unpublished data). On the basis of
the available literature and observations made during this
study, the addition of the pole-to-ground contact experi-
enced during polestriding is hypothesized to provide ben-
eficial changes in walking that afford the individual with
PAD mechanical and physiologic advantages. Wilson et al12
have shown that walking poles enable the individual to walk
at increased speed and stride length, that vertical ground
and knee joint reaction forces are reduced, and that knee
extensor angular impulse is greater (“more flexed knee
position through stance, reducing the bone on bone forces
and increasing the internal [muscular] knee extensor kinet-
ics”). They posit, “This reduction of lower extremity stress
during a faster walking velocity may symbolize a less harm-
ful mode of exercise for healthy and pathologic populations
alike.” For individuals with PAD who use good poling
mechanics, better perfusion of the leg muscles may exist as
a result of the longer period of time the leg muscles are
relaxed between the toe off to heel strike phase of the
recovering (nonweight bearing) leg. Moreover, with re-
duced effect of ground reaction forces on the leg, less
tension may be created in the antigravity muscles contract-
ing to balance the forces. As a result, the accumulation of
metabolic byproducts, such as lactic acid, may be slowed,
thus extending the period of time the muscles of the lower
legs can perform aerobically and delaying the onset of
claudication pain caused by ischemia. This may explain why
most subjects in this study were able to walk further and for
longer on the first day of training.
This investigation methodology differs from previous
exercise studies13 in that repeated testing was conducted at
baseline to establish a stable initial assessment of exercise
tolerance before proceeding with the intervention proto-
col. Seventeen subjects (33%) needed a third test to estab-
lish a stable baseline (ie, within 10% on duration or 5% on
metabolic values). Repeated measures ANOVA was used to
establish that the differences between the three tests in
these 17 subjects were significant (F 6.12; P .01). Post
hoc pairwise comparisons were completed with Tukey test.
Significant differences were found between the first and
second tests (P  .008) and the first and third tests (P 
.003). No significant difference was found between the
second and third tests (P  .79). This finding strongly
suggests that when subjects with PAD are given only one
test at baseline, investigators may be underestimating the
individual’s true initial walking ability.
At baseline, the subject perceived walking ability score
(0.31  0.25) on the distance subscale of the WIQ was
Mean rating of perceived leg pain during CWT test for subjects in polestriding and nonexercise control conditions at
baseline and 24 weeks are plotted on exercise time up to 20 minutes. Curves are best-fit logarithmic function for each
relationship. Differences in relative positions of symbols/curves show significant effect of 6 months of polestriding
exercise on subject rating of perceived leg pain.
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comparable with a large sample of patients with PAD (n 
555).14 Regensteiner, Steiner, and Panzer1 reported signif-
icant improvements in perceived distance (26.5%) and
speed (68%) in 10 persons with PAD in a 12-week exercise
program. In contrast, after 12 weeks training in this study,
subjects reported a 115% improvement in perceived dis-
tance and 76% improvement in perceived walking speed.
However, little additional change occurred from 12 to 24
weeks. Perceived distance walked increased from a 115%
improvement to 121%, and speed declined slightly from
76% to 71% by 6 months, probably because the focus of
training was on distance walked and less on speed. Subjects
were encouraged to use the poles to walk as far as possible
before stopping because of claudication pain. No signifi-
cant changes were found in the control group (at 6 months,
perceived distance declined by 9% and speed improved by
7%). This randomized clinical trial provides empirical evi-
dence that 24 weeks of polestriding training significantly
improves quantitative and qualitative measures of the exer-
cise tolerance of persons limited by IC pain.
Implications. This is the first randomized clinical trial
to evaluate the efficacy of polestriding exercise for improv-
ing exertional tolerance in persons with lower extremity
vascular disease. Patients who polestride regularly would
benefit from improved cardiovascular fitness, increased ex-
ercise tolerance, lower perceived leg pain during moderate-
intensity walking, improved skeletal muscle strength and
endurance,13 and better weight control. In a rehabilitation
program with polestriding training, patients with favorable
responses in 4 to 8 weeks would be maintained on an
exercise program, thus potentially avoiding the need for
surgery. Conversely, nonresponders might best be served
with reevaluation for corrective bypass surgery. Accord-
ingly, the early response (	9 weeks) of patients in a
polestriding program could provide information useful in
determining whether a patient’s condition necessitated in-
vasive surgical procedures or whether structured exercise
therapy would be the most efficacious treatment of IC.
We thank Jeanette Dilan-Koetje, RN, Desi Avila, BS,
Linda Fehr, MS, Domenic Reda, PhD, and Brian Dunlap.
We also thank the veterans who volunteered to participate
in this investigation.
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DISCUSSION
Dr Walter McCarthy (Chicago, Ill). This is an important
study because of the large number of patients in the United States
who have intermittent claudication, sometimes estimated to be as
high as 70% of the population over 70 years old. I wondered if you
could speculate on the advantage of the polestriding over a tradi-
tional trained exercise walking program quantitatively. Patients
have been shown to increase their walking distance by a factor of 2
or so with an educated walking program. Does the polestriding
really offer an advantage?
Dr W. Edwin Langbein. We believe that it does. Our results
are comparable with what has been published in the literature.
Based on a recent study by Wilson, when the poles are used
properly, the stride length is increased so that the time from toe off
to heel contact is increased. We believe that this increases the
relaxation period sufficiently to allow for improved perfusion of the
exercising muscles. Secondly, the ground reaction forces are re-
duced, which decreases the amount of muscle tension necessary to
overcome the body weight. Theoretically, this should reduce the
rate at which metabolic byproducts build up in the exercising
muscles. We were surprised that once we gave the poles to the
patients and taught them how to polestride properly that on the
first day of training their comment frequently was “I haven’t
walked this far in years.” Our impression is that a distinct advantage
of the poles is that it gets the person up and moving quickly and
success experiences come early in the training program. We en-
courage patients to walk without poles as well, but the poles I
believe offer significant advantages. I think both walking and
polestriding are important modes of exercise for persons with
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peripheral artery disease. There is one disadvantage that we found
associated with the poles, and that was that some of the subjects felt
self-conscious when walking with the poles in public.
Moderator. Tell us, have you in any way compared walking
with poles with walking without poles or with any type of super-
vised exercise program?
Dr Langbein. We did not compare them directly; however,
as I noted, the poles were not used during exercise testing, so
essentially the testing circumstances in our study were similar to
the testing circumstances in other studies. We already knew that
walking exercise was effective, and so there was no point in
reproving that. We wanted to demonstrate the benefit of polestrid-
ing. In addition, we have had success with polestriding in other
groups that have disabilities, such as osteoarthritis, Parkinson’s
disease, and congestive heart failure. In each case, the poles have
been effective in increasing the ability of the individual to sustain
exercise.
Dr James McKinsey (Chicago, Ill). My question kind of
goes along with Peter’s. It seems like the trial or study should be
done comparing it with a straight well-organized exercise pro-
gram. Is this really just a study? Because they are actively being
followed and doing it, they are going to participate more in it. So,
that is the first question.
The second question goes to your last statement: what was the
overall physical ability of the patients? Because many of our pa-
tients, too, we see with either an other-sided amputation or severe
osteoarthritis. Does this help stabilize the patient rather than just
decreasing their work of walking?
Dr Langbein. I have already forgotten the first question.
Dr McKinsey. The simple question is, is this not just an
organizational issue rather than a difference between an ambula-
tory program and pole walking? Because I think a lot of our
patients we see improve when they really do the exercise program
and so you need to compare an exercise program with pole
walking. The question that was going to go with that is did you see
an earlier improvement? Because generally with an exercise pro-
gram it takes several weeks before they start seeing improvement.
With this additional aide, are they up and walking quicker and
further?
Dr Langbein. We saw a very significant improvement at 4
weeks in those who participated in the study. In answer to the more
difficult question regarding organization, which I interpret to
mean, what would happen if you just left people on their own to
train? Our experience provides some insight into this question. We
attempted to titrate subjects away from the three times per week
supervised training program. We reduced the supervised sessions
to two and then to one time per week. Fifty percent of our subjects
were noncompliant in the absence of supervision. We offered these
subjects the opportunity to return to the program and resume the
supervised training. One hundred percent accepted the offer and
became fully compliant again. The presence of our exercise physi-
ologists who were very good had a marked effect on subjects’
participation in the study.
Moderator. What percentage of your patients could not par-
ticipate in this type of exercise?
Dr Langbein. Of those that were randomized into the study,
we lost six, or 10% of the patients. Of the six, three were removed
from the study for medical reasons, one person because he moved
to a different city, and the other two people chose, after random-
ization, to withdraw from the study before they began training.
They left after they completed the baseline testing.
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